Metastatic Bladder Cancer

The FDA approved enfortumab vedotin-ejfv in combination with pembrolizumab for patients with locally advanced or metastatic urothelial cancer, according to an agency press release.

On Oct. 25, 2016, HemOnc Today published an editorial titled “Animal Farm, 1984 and The Hunger Games,” which warned members of the electorate to be thoughtful about their imminent decisions and predicted a time of dystopia, contingent on the outcome.